2. Signaling Pathways
  3. Anti-infection
  4. Bacterial

Bacterial

Bacterial

Related Products

PDF 14.26 MB

Anything that destroys bacteria or suppresses their growth or their ability to reproduce. Heat, chemicals such as chlorine, and antibiotic drugs all have antibacterial properties. Many antibacterial products for cleaning and handwashing are sold today. Such products do not reduce the risk for symptoms of viral infectious diseases in otherwise healthy persons. This does not preclude the potential contribution of antibacterial products to reducing symptoms of bacterial diseases in the home.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-66011AS5
    Moxifloxacin-d5
    		Inhibitor
    Moxifloxacin-d5 (BAY 12-8039-d5 (free base)) is deuterium labeled Moxifloxacin. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.
    Moxifloxacin-d<sub>5</sub>
  • HY-136348
    ML338
    		Inhibitor
    ML338 is a selective small molecule inhibitor probe of non-replicating Mycobacterium tuberculosis bacilli and is against the non-replicating M. tuberculosis with IC90 and IC99 values of 1 μM and 4 μM, respectively by CFU. ML338 is a invaluable tool for identifying both essential functions and vulnerabilities of the M. tuberculosis bacilli in the nutrient deprivation states. ML338 can be used for the study of M. tuberculosis chemotherapy.
    ML338
  • HY-180116
    β-Lactamase-IN-11
    		Inhibitor
    β-Lactamase-IN-11 is a β-Lactamase Inhibitor with an IC50 of 30.37 μM. β-Lactamase-IN-11 exhibits significant antibacterial activity against Staphylococcus aureus and Pseudomonas aeruginosa, demonstrating potential for combating various drug-resistant bacteria. β-Lactamase-IN-11 can be used for studying infections caused by enzyme-producing drug-resistant bacteria.
    β-Lactamase-IN-11
  • HY-169219
    DK06
    		Inhibitor
    DK06 (compund DK06) inhibits the growth of Listeria monocytogenes, disrupts biofilm formation and reduces extracellular polymeric substances.
    DK06
  • HY-N13978
    Carpetimycin B
    		Inhibitor
    Carpetimycin B has very strong activity against Gram-positive and negative bacteria (including β-lactamase producing bacteria). Carpetimycin B has a strong inhibitory effect on β-lactamase.
    Carpetimycin B
  • HY-175835
    DXPS-IN-2
    		Inhibitor
    DXPS-IN-2 (compound 19) is a 1-deoxy-d-xylose 5-phosphate synthase (DXPS) inhibitor. DXPS-IN-2 has antibacterial activity and is useful for studying infections caused by Klebsiella pneumoniae.
    DXPS-IN-2
  • HY-W713365
    Eltrombopag-d3
    		Inhibitor
    Eltrombopag-d3 (SB-497115-d3) is deuterium labeled Eltrombopag. Eltrombopag (SB-497115) is an orally active thrombopoietin receptor nonpeptide agonist. Eltrombopag owns thrombopoietic activity, and has been used to research low blood platelet counts with chronic immune thrombocytopenia. Eltrombopag can be used for the research of cardiovascular. Eltrombopag also has highly inhibitory effects against multidrug resistant Staphylococcus aureus. Eltrombopag can induce apoptosis in hepatocellular carcinomab (HCC) as well.
    Eltrombopag-d<sub>3</sub>
  • HY-180459
    FabH-IN-3
    		Inhibitor
    FabH-IN-3 (Compound 12) is an inhibitor of FabH. FabH-IN-3 exhibits MIC against Bacillus subtilis, Escherichia coli, Pseudomonas fluorescens, and Staphylococcus aureus are all 50 μg/mL. FabH-IN-3 can be used for research on Gram-negative bacterial infections.
    FabH-IN-3
  • HY-B1907R
    Rifamycin sodium (Standard)
    		Inhibitor
    Rifamycin (sodium) (Standard) is the analytical standard of Rifamycin (sodium). This product is intended for research and analytical applications. Rifamycin sodium (Rifamycin SV sodium) is an orally active ansamycin antibiotic. Rifamycin sodium inhibits DNA-dependent RNA synthesis. Rifamycin sodium has antibacterial activity against Mycobacterium tuberculosis. Rifamycin sodium interferes with hepatic bile acid metabolism. Rifamycin sodium has anti-inflammatory effects. Rifamycin sodium can be used in the study of Mycobacterium tuberculosis, Bacteroides fragilis infection, and Lipopolysaccharide (HY-D1056B3)-induced inflammation.
    Rifamycin sodium (Standard)
  • HY-125066
    Reveromycin B
    Reveromycin B is a spiroketal bacterial metabolite originally isolated from Streptomyces. It inhibits EGF-induced mitogenic activity in Balb/MK cells (IC50=6 μg/mL) and exhibits pH-dependent antifungal activity against C. albicans (MICs=15.6 and >500 μg/mL at pH 3.0 and 7.4, respectively). Unlike reveromycin A and reveromycin C, reveromycin B does not inhibit proliferation of KB and K562 cells.
    Reveromycin B
  • HY-167906
    Lunamarine
    Lunamarine is a inhibitor of PDE5 with BBB permeability. Lunamarine can be used in the reseach of Pulmonary Arterial Hypertension (PAH) and Erectile Dysfunction (ED).
    Lunamarine
  • HY-161937
    Antibacterial agent 236
    		Inhibitor
    Antibacterial agent 236 (Compound 4l) is an orally active inhibitor for DNA gyrase and topoisomerase IV (IC50 is 3.2 and 300 nM in Staphylococcus aureus), and exhibits board-spectrum antibacterial activity. Antibacterial agent 236 exhibits good pharmacokinetic properties in mice.
    Antibacterial agent 236
  • HY-14865BR
    Omadacycline tosylate (Standard)
    		Inhibitor
    Omadacycline (tosylate) (Standard) is the analytical standard of Omadacycline (tosylate). This product is intended for research and analytical applications. Omadacycline (PTK 0796) tosylate, a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline tosylate acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline tosylate possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline tosylate can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections.
    Omadacycline tosylate (Standard)
  • HY-B0134B
    Bestatin trifluoroacetate
    		Inhibitor
    Bestatin trifluoroacetate is an inhibitor of CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase, used for cancer research.
    Bestatin trifluoroacetate
  • HY-B0914AR
    10-Undecenoic acid zinc salt (Standard)
    		Inhibitor
    10-Undecenoic acid (zinc salt) (Standard) is the analytical standard of 10-Undecenoic acid (zinc salt). This product is intended for research and analytical applications. 10-Undecenoic acid zinc salt (Undecylenic acid zinc salt) is an antifungal agent. 10-Undecenoic acid zinc salt inhibits Aβ oligomerization, scavenges ROS and inhibits μ-calpain activity. 10-Undecenoic acid zinc salt has neuroprotective effects. 10-Undecenoic acid zinc salt has anticancer effects on a variety of tumors. 10-Undecenoic acid zinc salt inhibits C. albicans biofilm formation and MRSA infection. 10-Undecenoic acid zinc salt inhibits quorum sensing signals of Bacillus subtilis and Pseudomonas aeruginosa.
    10-Undecenoic acid zinc salt (Standard)
  • HY-N12076
    11-Deoxydoxorubicin
    		Inhibitor
    11-Deoxydoxorubicin has anti-Gram-positive bacteria, negative bacteria and tumor activity.
    11-Deoxydoxorubicin
  • HY-181107
    DNA Gyrase/ribosomes-IN-1
    		Inhibitor
    DNA Gyrase/ribosomes-IN-1 is a bacterial ribosome and DNA gyrase inhibitor, with IC50 values of 1.11 μM and 3.31 μM, respectively. DNA Gyrase/ribosomes-IN-1 also inhibits CYP3A4, with an IC50 of 18.5 μM, and exhibits stability in mouse plasma and liver microsomes. DNA Gyrase/ribosomes-IN-1 inhibits bacterial protein synthesis by interacting with ribosomal RNA and associated sites. DNA Gyrase/ribosomes-IN-1 suppresses bacterial DNA replication by interacting with the gyrase complex. DNA Gyrase/ribosomes-IN-1 restores activity against macrolide-resistant, erm-mediated Gram-positive pathogens and enhances activity against Gram-negative bacteria such as Haemophilus influenzae and Moraxella catarrhalis. DNA Gyrase/ribosomes-IN-1 can be used in research on community-acquired bacterial pneumonia.
    DNA Gyrase/ribosomes-IN-1
  • HY-N14515
    Saframycin G
    		Inhibitor
    Saframycin G has the effect of anti-Gram-positive bacteria. Saframycin G has the effect of inhibiting mouse lymphocyte L-1210 with an ID50 of 0.03 μM.
    Saframycin G
  • HY-126151
    Heneicomycin
    		Inhibitor
    Heneicomycin has anti-Gram-positive bacteria, negative bacteria and mycoplasma activities, and has the effect of promoting animal growth.
    Heneicomycin
  • HY-N13985
    Arylomycin B6
    		Inhibitor
    Arylomycin B6 is a lipohexapeptide antibiotic against Gram-positive bacteria.
    Arylomycin B6
Cat. No. Product Name / Synonyms Application Reactivity